LY-235497

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLY-235497
Drug Alias NameLY-235497
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonistsGlutamate [NMDA] receptor antagonists
TargetsGlutamate receptor ionotropic AMPAGlutamate [NMDA] receptor
Therapy Area/IndicationsCraniocerebral TraumaStrokeCerebral Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsCraniocerebral TraumaStrokeCerebral Infarction

Other Information

ATC CodeN/A
Related LinksN/A